J. Zeffren
- Oncology top 10%
- Immunology top 10%
- Pathology and Forensic Medicine top 5%
- Dermatology top 2%
- Pulmonary and Respiratory Medicine
- Co-authors
- Robin T. VollmerJohn E. UltmannDaina VariakojisElise A. OlsenSteven T. RosenNancy P. MoldawerH. HeinemannRobert A. Figlin
- Topics
- Cancer Immunotherapy and Biomarkers (6 papers)Renal cell carcinoma treatment (4 papers)Immunotherapy and Immune Responses (4 papers)
- Partner nations
- United StatesSwitzerlandIndia
In The Last Decade
J. Zeffren
18 papers receiving 709 citations
Peers
Comparison fields: 5 of 68
- Oncology 325
- Immunology 304
- Pathology and Forensic Medicine 247
- Dermatology 177
- Pulmonary and Respiratory Medicine 139
Countries citing papers authored by J. Zeffren
This map shows the geographic impact of J. Zeffren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Zeffren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Zeffren more than expected).
Fields of papers citing papers by J. Zeffren
This network shows the impact of papers produced by J. Zeffren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Zeffren. The network helps show where J. Zeffren may publish in the future.
Co-authorship network of co-authors of J. Zeffren
This figure shows the co-authorship network connecting the top 25 collaborators of J. Zeffren. A scholar is included among the top collaborators of J. Zeffren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Zeffren. J. Zeffren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 19 | |
| 3 | 95 | |
| 4 | 23 | |
| 5 | 10 | |
| 6 | 14 | |
| 7 | 22 | |
| 8 | 57 | |
| 9 | Biologic therapy of cancer. | 3 |
| 10 | 27 | |
| 11 | 156 | |
| 12 | Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate. | 13 |
| 13 | 205 | |
| 14 | Phase II trial of methyl-GAG in advanced renal cancer. | 14 |
| 15 | 42 | |
| 16 | 44 | |
| 17 | 3 | |
| 18 | Effects of prolonged tolbutamide therapy on hepatic function and serum cholesterol of adult diabetic patients. | 4 |
About J. Zeffren
J. Zeffren is a scholar working on Oncology, Immunology and Nephrology, having authored 18 papers that have together received 772 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Dermatology (177 citations), Immunology (304 citations) and Pathology and Forensic Medicine (247 citations). J. Zeffren has collaborated with scholars based in United States, Switzerland and India. Frequent co-authors include Robin T. Vollmer, John E. Ultmann, Daina Variakojis, Elise A. Olsen, Steven T. Rosen, Nancy P. Moldawer, H. Heinemann, Robert A. Figlin, Jean B. deKernion and Arie S. Belldegrun. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.